RIVA-DAPSONE
Identification of Riva-Dapsone
| No description |
Google image searchProduct monograph
Active ingredient
dapsone, 100 MG
DIN: 02489058
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 21-AUG-2019
ATC:
- J04 — ANTIMYCOBACTERIALS (ATC, ATC/DDD, )
- J04B — DRUGS FOR TREATMENT OF LEPRA (ATC, ATC/DDD)
- J04BA — Drugs for treatment of lepra (ATC, ATC/DDD)
- J04BA02 — DAPSONE (ATC/DDD)
Reference brand drug: Avlosulfon
Pharmaceutical standard: USP
